27 de octubre de 2014 / 14:03 / en 3 años

REFILE-BUZZ-U.S. Stocks on the Move-Brazil companies, Chembio, Pain Therapeutics

(Corrects item 1 to say "her", not "his". The error also occurred in the earlier version of U.S. Stocks on the Move) (For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s)

U.S. stock indexes fell on Monday. The Dow Jones industrial average was down 0.37 percent at 16,743.49, the S&P 500 was down 0.55 percent at 1,953.77 and the Nasdaq Composite was down 0.60 percent at 4,456.877.



** BANCO BRADESCO SA, $12.64, -8.01 pct

** ITAU UNIBANCO HOLDING SA, $12.59, -6.67 pct

** VALE SA, $10.475, -6.14 pct

Brazilian companies’ U.S.-listed shares fell after Dilma Rousseff narrowly won presidential election on Sunday, beating her pro-business rival Aecio Neves. Investors are skeptical about Rousseff’s ability to turn around a troubled economy after four years of ineffective industrial policies

** SCHLUMBERGER LTD, $93.36, -3.99 pct

** BAKER HUGHES, $51.53, -3.66 pct


Brokerage firm Goldman Sachs cut its price targets on shares of oilfield services providers, saying it expected West Texas Intermediate to average $73.75 per barrel in 2015, down from $94.83 in 2014. It also said it expected global benchmark Brent crude to average $83.75, down from $101.82 in 2014.

** NOVAVAX INC, $5.4101, +5.46 pct

The drug developer said it had begun a non-human primate study on Ebola vaccine candidate and that it expected to start early-stage trial in December.


Brazilian juice maker Grupo Cutrale and investment firm Safra Group agreed on Monday to acquire U.S.-based banana producer Chiquita in a deal valued at $1.3 billion.

** MERCK & CO, $56.95, -1.15 pct

The No. 2 U.S. drugmaker reported lower-than-expected revenue for the third quarter, hurt by sharply lower sales of its Gardasil vaccine against cervical cancer, but cost cuts enabled the company to beat earnings forecasts.

** SAREPTA THERAPEUTICS INC, $15.6511, -33.57 pct

The drugmaker said the U.S. Food and Drug Administration had requested additional data regarding the marketing application for its experimental muscle disorder drug, eteplirsen.

** PAIN THERAPEUTICS INC, $1.64, -60.48 pct

** DURECT CORP, $0.77, -44.60 pct

Drugmaker Pain Therapeutics said Pfizer Inc had terminated the development of its drug abuse resistant painkiller, Remoxy. The actual termination will come into effect six months from Monday, the company said. Remoxy was being developed using Durect’s abuse resistant technology.

** CHEMBIO DIAGNOSTICS INC, $4.7, +17.80 pct

The medical test maker’s shares rose as much as 31 percent to $5.20, their highest in 15 months after the company said it would develop point-of-care diagnostic tests for Ebola and febrile illness, in partnership with privately held Integrated BioTherapeutics Inc. Chembio will have exclusive rights to any point-of-care product developed under the deal.

** SANOFI SA, $52.71, -2.43 pct

The French pharmaceutical company’s board of directors said Chief Executive Chris Viehbacher’s succession was not on the agenda of a meeting scheduled for later on Monday, after Les Echos newspaper reported that the board may address the subject.

** WILLIAMS COMPANIES INC, $52.53, -1.33 pct

** WILLIAMS PARTNERS LP, $50.33, +0.66 pct


Pipeline operator William Companies, which owns controlling interests in Williams Partners and Access Midstream, said the two master limited partnerships had amended the terms of their merger agreement. Under the revised terms, Williams Partners will merge with a subsidiary of Access Midstream in a unit-for-unit exchange of 0.86672 common units of Access Midstream for every Williams common unit.

** FREEPORT-MCMORAN INC, $30.33, -1.53 pct

Workers at the miner’s giant Indonesian copper mine will hold a one-month strike from next week, a union official said on Monday, after the company failed to make changes to local management following a fatal accident.

** CONTINENTAL RESOURCES INC, $53.09, -6.42 pct

South Korea’s SK E&S Co Ltd said on Monday that it had bought a $360 million stake in a shale gas reserve from U.S. oil driller Continental, adding that the companies would co-develop the reserve and start production from 2017. (Compiled by Yashaswini Swamynathan in Bangalore; Editing by Kirti Pandey)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below